Amneal Pharmaceuticals Stock Quote AMRX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

7.33

Bid

7.30

Ask

7.47

Volume

1,394,017

7.36 Day's Range 7.67

5.01 52 Week Range 7.735

Market Cap

2.262B

Previous Close

7.45

Open

7.45

Last Trade

7.3

Last Trade Time

Financial Volume

$ 10,413,568

VWAP

7.4702

Average Volume (3m)

1,477,730

Shares Outstanding

308,651,373

Dividend Yield

PE Ratio

-21.57

Earnings Per Share (EPS)

-0.27

Revenue

2.41B

Net Profit

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amneal.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was $7.45. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of $ 5.01 to $ 7.735.

Amneal Pharmaceuticals currently has 308,651,373 shares outstanding. The market capitalization of Amneal Pharmaceuticals is $2.30 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.57.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.14	-1.87416331995	7.47	7.735	7.15	955954	7.41241113	CS
4	0.77	11.737804878	6.56	7.735	6.29	1508282	6.75128326	CS
12	1.44	24.4482173175	5.89	7.735	5.81	1477730	6.70627906	CS
26	1.84	33.5154826958	5.49	7.735	5.01	1506677	6.15551216	CS
52	1.45	24.6598639456	5.88	7.735	5.01	1506532	6.09972831	CS
156	1.45	24.6598639456	5.88	7.735	5.01	1506532	6.09972831	CS
260	1.45	24.6598639456	5.88	7.735	5.01	1506532	6.09972831	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF	20.10 (839.25%)	128.82k
RGCRegencell Bioscience Holdings Ltd	$ 15.15 (349.55%)	1.34M
ATPCAgape ATP Corporation	$ 0.2262 (58.18%)	107.31M
SLRXSalarius Pharmaceuticals Inc	$ 2.34 (51.95%)	60.04M
GSUNGolden Sun Health Technology Group Ltd	$ 7.46 (45.42%)	589.98k
FLYEFly E Group Inc	$ 1.1601 (-81.82%)	25.44M
RNAZTransCode Therapeutics Inc	$ 0.3035 (-61.70%)	9.78M
JAGXJaguar Health Inc	$ 1.755 (-58.90%)	15.47M
MIRAMIRA Pharmaceuticals Inc	$ 2.55 (-49.10%)	25.64M
IVPInspire Veterinary Partners Inc	$ 5.19 (-43.83%)	1.67M
SLNASelina Hospitality PLC	$ 0.026 (-29.73%)	220.32M
SPWRSunPower Corporation	$ 0.9514 (32.91%)	186.76M
NVDANVIDIA Corporation	$ 122.59 (-0.77%)	173.9M
ADILAdial Pharmaceuticals Inc	$ 1.3422 (26.62%)	160.04M
HOLOMicroCloud Hologram Inc	$ 0.588 (26.07%)	135.56M